Clinical Trial Update: The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of simvastatin on Th17 cytokines in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Mahidol University | Conditions: COPD | Phase 3 | Status: COMPLETED